for amblyopia – sometimes known as lazy eye – has been shown to improve vision correction over standard therapy in a phase 3 trial, according to its developer Luminopia. The DTx – called ...
Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows.
she did not have amblyopia, had early surgery and, in other ways, may have been an ideal candidate for the therapy that she received. Moreover, much of the literature on visual training therapy is ...
Amblyopia is relatively common in children ... Using eye drops to blur vision in the stronger eye temporarily Vision therapy to improve eye coordination and visual processing skills.
Amblyopia is due to an inadequate development ... It is not possible to deduce from the available data whether additional occlusion therapy enhanced the effect of the digital intervention.